Bioinova, s.r.o. is rated 3 out of 5 in the category biotechnology. Read and write reviews about Bioinova, s.r.o.. Production of therapeutically acting cell lines (somatocellular therapy) under the GMP regulations, FDF - final dosage forms, project management and development in GMP. Currently running and/or preparing multiple clinical trials with mesenchymal stem cells. Contractual manufacturing GMP.
Company size
1-10 employees